Protara Therapeutics, Inc.
TARA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$40 | -$66 | -$47 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $6 | $7 | $10 |
| Change in WC | $4 | -$4 | $1 | $1 |
| Other Non-Cash | $0 | $1 | $32 | $2 |
| Operating Cash Flow | -$36 | -$38 | -$26 | -$35 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$29 | -$12 | -$44 | -$125 |
| Inv. Sales/Matur. | $49 | $65 | $59 | $27 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $19 | $53 | $15 | -$98 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $136 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$0 | -$0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | $0 | $0 | $0 |
| Financing Cash Flow | $140 | -$0 | -$0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $123 | $15 | -$12 | -$133 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $25 | $36 | $169 |
| End Cash | $164 | $40 | $25 | $36 |
| Free Cash Flow | -$36 | -$38 | -$27 | -$35 |